CAR-T cells leave the comfort zone: current and future applications beyond cancer

Chimeric antigen receptor (CAR)-T cell therapy represents a breakthrough in the immunotherapy field and has achieved great success following its approval in 2017 for the treatment of B cell malignancies. While CAR-T cells are mostly applied as anti-tumor therapy in the present, their initial concept...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzi, Mariana Torres, Hajdu, Karina Lôbo, Ribeiro, Priscila Rafaela, Bonamino, Martín Hernán
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Adoptive Cellular Immunotherapies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585679/
https://www.ncbi.nlm.nih.gov/pubmed/36284896
http://dx.doi.org/10.1093/immadv/ltaa006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585679/
https://www.ncbi.nlm.nih.gov/pubmed/36284896
http://dx.doi.org/10.1093/immadv/ltaa006

Ejemplares similares